C1Q POSITIVE ANTIBODIES IN PATIENTS WITH DONOR SPECIFIC HLA ANTIBODIES AND POST TRANSPLANT REJECTION

被引：0
|
作者：
Saltarrelli, Jerome G. [1 ]
Lappin, Jacqueline A. [1 ]
Katz, Stephen M. [1 ]
Varga, Karoly [1 ]
Van Buren, Charles T. [1 ]
Bihari, Laszlo A. [1 ]
Cook, Daniel J. [1 ]
Tyan, Dolly [2 ]
Kerman, Ronald H. [1 ]
Chen, Ge [1 ]
机构：
[1] Univ Texas Houston, Sch Med, Houston, TX USA
[2] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
来源：
HUMAN IMMUNOLOGY | 2011年 / 72卷
关键词：
D O I：
10.1016/j.humimm.2011.07.119
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [31] Long Term Outcome of First-Year C1q Positive Donor Specific Antibodies After Heart Transplantation
    Chang, D.
    Patel, J.
    Kittleson, M.
    Welton, M.
    Bhatnagar, N.
    Kanungo, A.
    Lee, M.
    Wakefield, Z.
    Hamilton, M.
    Hage, A.
    Czer, L.
    Catarino, P.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S109 - S109
  • [32] Significance of Pre Transplant Donor Specific HLA Antibodies and Post Transplant Cardiac Allograft Vasculopathy
    Gandhi, M. J.
    De Goey, S. R.
    Periera, N.
    Kushwaha, S.
    Edwards, B.
    Park, S.
    Clavell, A.
    Schirger, J.
    Rodeheffer, R.
    Frantz, R.
    Daly, R. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S158 - S158
  • [33] TWO KIDNEY RECIPIENTS WITH GOOD FUNCTION AND DONOR SPECIFIC ANTIBODIES POSITIVE FOR C1Q AND IGG4 SUBCLASS
    Cicciarelli, James C.
    Lemp, Nathan A.
    Kasahara, Noriyuki
    Burns, Kevin
    Williams, Bruce
    Bloom, Sheila
    Montes, Rolando
    Pitpitan, Bennie
    Brown, Barry
    Steinberg, Steven
    HUMAN IMMUNOLOGY, 2015, 76 (04) : 222 - 222
  • [34] TRANSPLANT OUTCOMES IN PATIENTS WITH DE NOVO DONOR SPECIFIC ANTIBODIES POST TRANSPLANT
    Pochinco, Denise
    Kelm, Dawn
    Kendra, Hacking
    Blydt-Hansen, Tom
    Rush, David
    Gibson, Ian
    Nickerson, Peter
    HUMAN IMMUNOLOGY, 2009, 70 : S65 - S65
  • [35] Reduction of HLA donor specific antibodies in heart transplant patients treated with proteasome inhibitors for antibody mediated rejection
    Horn, Edward T.
    Xu, Qingyong
    Dibridge, Julie N.
    Huston, Jessica H.
    Hickey, Gavin W.
    Kaczorowski, David J.
    Keebler, Mary E.
    Zeevi, Adriana
    CLINICAL TRANSPLANTATION, 2023, 37 (12)
  • [36] Positive Solid Phase C1q Assays in Patients with Antibody-Mediated Rejection Correlate with the Presence of HLA Antibodies with High MFI Values.
    Ellis, T.
    Yell, M.
    Muth, B.
    Brown, P.
    Djamali, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 159 - 159
  • [37] Questioning the Added Value of Luminex Single Antigen Beads to Detect C1q Binding Donor HLA-Specific Antibodies
    Peacock, Sarah
    Kosmoliaptsis, Vasilis
    Bradley, Andrew J.
    Taylor, Craig J.
    TRANSPLANTATION, 2014, 98 (04) : 384 - 386
  • [38] CARDIAC TRANSPLANTATION OF HIGHLY SENSITIZED PATIENTS ACROSS C1Q NEGATIVE HLA ANTIBODIES
    Waslaske, Sheree H.
    Nickels, Lauren
    Nasse, Cheryl L.
    Titchener, E. Haywood
    Cellars, Karen A.
    Savage, Andrew J.
    Moussa, Omar
    HUMAN IMMUNOLOGY, 2012, 73 : 82 - 82
  • [39] Donor-specific HLA Antibodies for Risk Stratification of Antibody-Mediated Transplant Rejection
    Dick, Andrea
    Kugyelka, Reka
    Humpe, Andreas
    Kauke, Teresa
    TRANSFUSIONSMEDIZIN, 2024, 14 (04) : 209 - 218
  • [40] Role of Non-Donor Specific HLA Antibodies (NDSA) in Kidney Transplant Rejection.
    Krum, K.
    Fagoga, O.
    Doshi, M.
    TRANSPLANTATION, 2014, 98 : 435 - 435
12345